B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Sunitinib

300 PubMed studies analyzed · 10 RCTs · Evidence Score: 44.2

Research Domains

Sunitinib has been studied across 17 research domains including 🔬 Oncology, 🫘 Kidney, ⏳ Longevity & Aging, 🧬 Hormones, 🫁 Liver & Detox. The primary research focus is 🔬 Oncology with 77% of studies addressing this area.

Loading evidence profile...

This evidence profile for Sunitinib is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.